Evidence map›Paper›PMID 34357827›Full record

ArticleHuman vaccines & immunotherapeutics2021

SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.

Tina Ko, Claire Dendle, Ian Woolley, Eric Morand, Anna Antony

Registry-linked trialAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05479383 (Tobacco Use and Uptake of COVID-19 Vaccinations in Finland), which is not on this map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05479383 unknown statusnot on this map

Tobacco Use and Uptake of COVID-19 Vaccinations in Finland: a General Population Study

TypeobservationalSponsorFinnish Institute for Health and WelfareRan2017 to 2023Enrolled42,935ConditionsCOVID-19, Smoking, Tobacco Use, Vaccination RefusalArmsNot applicable, this is an observational study
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Kidney transplant recipients' attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tina KoDepartment of Rheumatology, Monash Health, Clayton, Australia.ORCID 0000-0002-1166-1440
Claire DendleDepartment of Infectious Diseases, Monash Health, Clayton, Australia.
Ian WoolleyDepartment of Infectious Diseases, Monash Health, Clayton, Australia.ORCID 0000-0003-2928-1291
Eric MorandDepartment of Rheumatology, Monash Health, Clayton, Australia.
Anna AntonyDepartment of Rheumatology, Monash Health, Clayton, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine acceptance among patients with rheumatic diseases (RMD).

methodsAll rheumatology patients attending a large suburban health network were invited to participate in an anonymized online survey. The primary outcome of interest was SARS-COV-2 vaccine acceptance.

resultsThe mean (SD) age of respondents (n = 641) was 52.7 (15.1) years and 74.4% (n = 474) were female. Sixty-five percent were willing to have a SARS-COV-2 vaccine, while 34.4% were vaccine-hesitant (unwilling or undecided). On multivariate analysis, vaccine acceptance was associated with smoking (OR: 2.25 [95% CI: 1.22-4.15;

conclusionSARS-COV-2 vaccine hesitancy is prevalent amongst RMD patients and associated with concerns regarding vaccine safety, efficacy, side effects and RMD flare. Clinician recommendation, vaccine choice and communications targeting patient concerns could facilitate vaccine acceptance.

Indexed as

COVID-19Influenza VaccinesRheumatic DiseasesCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansMiddle AgedSARS-CoV-2VaccinationVaccination HesitancyVaccine EfficacyCOVID-19 VaccinesInfluenza VaccinesCoronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); vaccination; rheumatic disease (RMD)

Identifiers

PMID34357827
PMCPMC8828082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.